Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders
Open Access
- 29 January 2015
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 52 (3) , 208-216
Abstract
Background Neuromuscular disorders are a clinically, pathologically, and genetically heterogeneous group. Even for the experienced clinician, an accurate diagnosis is often challenging due to the complexity of these disorders. Here, we investigated the utility of next generation sequencing (NGS) in early diagnostic algorithms to improve the diagnosis for patients currently lacking precise molecular characterisation, particularly for hereditary myopathies. Methods 43 patients presenting with early onset neuromuscular disorders from unknown genetic origin were tested by NGS for 579 nuclear genes associated with myopathy. Results In 21 of the 43 patients, we identified the definite genetic causes (48.8%). Additionally, likely pathogenic variants were identified in seven cases and variants of uncertain significance (VUS) were suspected in four cases. In total, 19 novel and 15 known pathogenic variants in 17 genes were identified in 32 patients. Collagen VI related myopathy was the most prevalent type in our cohort. The utility of NGS was highlighted in three cases with congenital myasthenia syndrome, as early diagnosis is important for effective treatment. Conclusions A targeted NGS can offer cost effective, safe and fairly rapid turnaround time, which can improve quality of care for patients with early onset myopathies and muscular dystrophies; in particular, collagen VI related myopathy and congenital myasthenia syndromes. Nevertheless, a substantial number of patients remained without molecular diagnosis in our cohort. This may be due to the intrinsic limitation of detection for some types of mutations by NGS or to the fact that other causative genes for neuromuscular disorders are yet to be identified.Keywords
This publication has 48 references indexed in Scilit:
- Congenital myopathies – Clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United KingdomNeuromuscular Disorders, 2013
- Relative frequency of congenital muscular dystrophy subtypes: Analysis of the UK diagnostic service 2001–2008Neuromuscular Disorders, 2012
- Consensus Statement on Standard of Care for Congenital MyopathiesJournal of Child Neurology, 2012
- Prevalence of congenital myopathies in a representative pediatric united states populationAnnals of Neurology, 2011
- Consensus Statement on Standard of Care for Congenital Muscular DystrophiesJournal of Child Neurology, 2010
- Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic populationBrain, 2009
- Diagnosis and etiology of congenital muscular dystrophyNeurology, 2008
- Congenital muscular dystrophies: New aspects of an expanding group of disordersBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Neuromuscular disorders in childhood: a descriptive epidemiological study from western SwedenNeuromuscular Disorders, 2000
- The prevalence of inherited neuromuscular disease in Northern IrelandNeuromuscular Disorders, 1996